News | November 19, 2013

Esaote Showcases Prevention Suite at EuroEcho-Imaging 2013

Prevention Suite’s combined imaging technologies enable practical pre-clinical assessment of CVD risk

ultrasound systems cardiovascular esaote prevention suite euroecho RF
November 19, 2013 — Esaote will showcase Prevention Suite, a unique package of ultrasound imaging modalities for both cardiac and vascular investigations at the EuroEcho-Imaging 2013 conference Dec. 11-14 in Istanbul, Turkey.
 
Prevention Suite provides clinicians with a wide range of tools for assessing a patient’s risk of cardiovascular disease quickly and reliably, often before symptoms occur. It is regarded as providing a “step change” in terms of early detection and prevention of cardiovascular disease using ultrasound.
 
The four advanced technologies that make up Prevention Suite are CFI, XStrain, RF-QIMT and RF-QAS, which measure coronary flow quantification, cardiac deformation indexes, carotid intima-media thickness and arterial stiffness, respectively. The vascular measurements are performed using RF signal analysis, which provides high spatial resolution for greater accuracy.
 
Fausto Rigo, Cardiac Diagnostic Imaging Department head, Dell’Angelo Hospital, Mestre-Venice, Mestrem Italy and professor of sonography and echocardiography, University of Padua, Padua, Italy, has used Esaote’s Prevention Suite extensively in both inpatient and outpatient examinations. 
 
“For clinicians ranging from GPs (general practitioners) to cardiologists, Prevention Suite is a unique and technically superb ‘one-stop-shop’ for cardiovascular assessment. It allows us to quickly and reliably make an appraisal of the patient, providing information about the actual biological risk of atherosclerosis. Prevention Suite’s resolution for vessel analysis is particularly impressive. There is no equivalent that allows us this multiplicity of information in the pre-clinical phase. Patients are fascinated by the examination too, and Prevention Suites’ real-life images are highly persuasive in convincing them to modify their lifestyle.”
 
Reducing cardiovascular disease risk, cutting costs
Early detection approach using imaging of key cardiovascular regions can be an important way of addressing an extremely costly issue: In 2011, the American Heart Association (AHA) estimated that by 2030, the cost of treating cardiovascular diseases will rise from $273 billion to $818 billion.
 
“Atherosclerosis is one of the pathologies which can remain asymptomatic for a long time,” said Cristina Giannattasio, M.D., Ph.D., head of Cardiology IV, Cardiologic Department, Niguarda Hospital, Milan, Italy. “The availability of dedicated cardiac and vascular measurements in the same device offers a more user-friendly and comprehensive assessment with the benefit of being able to detect early risk of CV (cardiovascular) disease.” 
 
“In the future, preventative approaches will be the best way of reducing morbidity and mortality,” added Giannattasio.
                                                                                                                                                             
Ongoing clinical studies involving hundreds of patients at clinical centers throughout Europe have started to show the benefits of a preventative screening approach. 
 
“The integration of cardiac and vascular assessments will help physicians identify the actual biological risk of atherosclerosis,” said Rigo. “Once clinical risk is identified, clinicians can work with patients on early intervention strategies and lifestyle modification before the risk of CVD (cardiovascular disease) escalates. As well as having clear patient benefits, pre-clinical assessments may help prevent hospitalizations and acute therapies, yielding significant long-term cost savings.”
 
Prevention Suite is available across Esaote’s range of ultrasound products.  Technology and features are system/configuration dependent. Specifications are subject to change without notice. Information might refer to products or modalities not yet approved in all countries. XStrain 4-D and RF-QAS are not currently available in the United States.
 
For more information: www.esaote.com

Related Content

AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Digisonics Customers Expand OB Ultrasound Reporting Systems for Improved Workflow Efficiency
News | Ultrasound Imaging | February 06, 2018
February 6, 2018 – Oregon Health and Science University in Portland, Ore., University of Utah Medical Center in Salt
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
ASE Opens Enrollment for ImageGuideEcho Registry
News | Cardiovascular Ultrasound | January 29, 2018
January 29, 2018 — The American Society of Echocardiography (ASE) announced that ImageGuideEcho, a module under the I
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
New Vascular Ultrasound Registry Looks to Enhance Patient Care
News | Cardiovascular Ultrasound | January 17, 2018
The Society for Vascular Ultrasound (SVU), the Society for Vascular Surgery (SVS) and Medstreaming-M2S announced the...
Sponsored Content | Videos | Ultrasound Imaging | January 11, 2018
Mindray recently featured a new upgrade for its premium Resona 7 ultrasound system at the Radiological Society of North...
New International Report Provides Comprehensive Guide to Imaging in Chagas Heart Disease
News | Cardiovascular Ultrasound | January 03, 2018
Chagas disease (ChD), an infectious parasitic disease transmitted primarily by triatomine insects, has become a...
Bay Labs Completes $5.5 Million Series A Financing for AI-Driven Ultrasound
News | Cardiovascular Ultrasound | December 21, 2017
December 21, 2017 — Bay Labs, a medical technology company applying...
Overlay Init